Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02936999 · ClinicalTrials.gov registry record · Early Phase 1
Vitamin D Supplementation in Women With DCIS and/or LCIS
A Early Phase 1 study, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT02936999 is a Early Phase 1 study that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 8 participants.
The verdict
NCT02936999, a Early Phase 1 study, was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and usefulness of oral Vitamin D supplementation in subjects with in situ carcinoma. More specifically, this study is being done to (1) understand the effect of Vitamin D supplementation on behavior of breast cancer cells and (2) the development of invasive breast cancer disease.
Interventions
- DRUG Cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-08 |
| Est. Completion | 2019-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02936999
The ClinicalTrials.gov registry entry for NCT02936999 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cholecalciferol is the first listed.
NCT02936999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02936999 about?
NCT02936999 is a clinical study titled "Vitamin D Supplementation in Women With DCIS and/or LCIS". The purpose of this study is to determine the safety and usefulness of oral Vitamin D supplementation in subjects with in situ carcinoma. More specifically, this study is being done to (1) understand the effect of Vitamin D supplementation on behavior of breast cancer cells and (2) the development o...
What is the current status of trial NCT02936999?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2016-08. Estimated completion is 2019-01.
What interventions are being tested in trial NCT02936999?
The interventions under investigation include: Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT02936999?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.